stock outlook amid ERP challenges, growth targets By Investing.com
Zimmer Biomet Holdings Inc (NYSE:), a leading player in the U.S. Medical (TASE:) Supplies & Devices sector, has recently unveiled its ambitious Long Range Plan (LRP) amid ongoing Enterprise Resource Planning (ERP) implementation challenges. This comprehensive analysis examines the company’s strategic initiatives, financial performance, and market position to provide investors with a clear picture of ZBH’s current state and future prospects.
Company Overview
Zimmer Biomet operates in the medical devices industry, focusing on orthopedic and musculoskeletal products. The company’s core segments include Knees, Hips, and S.E.T. (Surgical, Equipment, and Trauma). With a market capitalization of $21.25 billion, ZBH maintains a significant…
